REGULATORY

PMDA Working Group to “Feed Back Experiences in Reviews” toward Creation of Clinical Innovation Network

July 20, 2016

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Pharmaceuticals and Medical Devices Agency (PMDA) is supporting the creation of a “clinical innovation network” (CIN) that will collect case information from a patient registry built by the national centers for advanced and specialized medical care and other research…

To read the full story

PMDA to Announce Evaluation Policy on Diagnosis Using Next-Generation Sequencers
July 21, 2016

REGULATORY

Panel to Weigh Orphan Designation for Tecartus on December 22
December 17, 2025
LDP League Formally Urges Male HPV Shots Under NIP from FY2026
December 17, 2025
Solo Distribution Poses Threats to Stable Supplies, Price Negotiations: Survey
December 17, 2025
MHLW Drafts Guideline Update, Urges Makers to Factor Distribution Costs into WPPs
December 16, 2025
MHLW to Add Company-Driven Route to “Specific-Use Drug” Designations
December 16, 2025

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…